Literature DB >> 29330114

Human CD4+ CD25+ CD127hi cells and the Th1/Th2 phenotype.

Aditi Narsale1, Rosita Moya1, Joanna Davida Davies2.   

Abstract

CD4+ T cells that co-express CD25 and CD127 (CD25+CD127+) make up around 20% of all circulating CD4+ memory T cells in healthy people. The clinical significance of these cells is that in children with type 1 diabetes their relative frequency at diagnosis is significantly and directly correlated with rate of disease progression. The purpose of this study was to further characterize the CD25+CD127hi cells. We show that they are a mix of Th1 and Th2 cells however, they have a significantly higher relative frequency of pre-committed and committed Th2 cells, and secrete significantly higher levels of Th2-type cytokines than CD25- memory T cells. Further, these cells are neither exhausted nor senescent and proliferate to the same extent as CD25- memory cells. Thus, CD25+CD127hi cells are a highly active subset of memory T cells that might play a role in controlling inflammation via anti-inflammatory Th2-type deviation.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  CD25(+)CD127(hi) cells; Chemokine receptors; Cytokines; T cell subsets; Th1 and Th2

Mesh:

Substances:

Year:  2018        PMID: 29330114      PMCID: PMC5826897          DOI: 10.1016/j.clim.2018.01.003

Source DB:  PubMed          Journal:  Clin Immunol        ISSN: 1521-6616            Impact factor:   3.969


  54 in total

Review 1.  Role of T lymphocyte replicative senescence in vaccine efficacy.

Authors:  Rita B Effros
Journal:  Vaccine       Date:  2006-09-07       Impact factor: 3.641

2.  CD44 promotes progenitor homing into the thymus and T cell maturation.

Authors:  Mohini Rajasagi; Mario Vitacolonna; Bojan Benjak; Rachid Marhaba; Margot Zöller
Journal:  J Leukoc Biol       Date:  2008-10-27       Impact factor: 4.962

3.  Inhibition of Th1 development mediated by GATA-3 through an IL-4-independent mechanism.

Authors:  W Ouyang; S H Ranganath; K Weindel; D Bhattacharya; T L Murphy; W C Sha; K M Murphy
Journal:  Immunity       Date:  1998-11       Impact factor: 31.745

Review 4.  Forms and functions of CD44.

Authors:  G Borland; J A Ross; K Guy
Journal:  Immunology       Date:  1998-02       Impact factor: 7.397

5.  CD28 expression in T cell aging and human longevity.

Authors:  N Boucher; T Dufeu-Duchesne; E Vicaut; D Farge; R B Effros; F Schächter
Journal:  Exp Gerontol       Date:  1998-05       Impact factor: 4.032

6.  CD44 costimulation promotes FoxP3+ regulatory T cell persistence and function via production of IL-2, IL-10, and TGF-beta.

Authors:  Paul L Bollyky; Ben A Falk; S Alice Long; Anton Preisinger; Kathy R Braun; Rebecca P Wu; Stephen P Evanko; Jane H Buckner; Thomas N Wight; Gerald T Nepom
Journal:  J Immunol       Date:  2009-07-27       Impact factor: 5.422

7.  Cutting edge: high molecular weight hyaluronan promotes the suppressive effects of CD4+CD25+ regulatory T cells.

Authors:  Paul L Bollyky; James D Lord; Susan A Masewicz; Stephen P Evanko; Jane H Buckner; Thomas N Wight; Gerald T Nepom
Journal:  J Immunol       Date:  2007-07-15       Impact factor: 5.422

8.  Type 1 diabetes immunotherapy using polyclonal regulatory T cells.

Authors:  Jeffrey A Bluestone; Jane H Buckner; Mark Fitch; Stephen E Gitelman; Shipra Gupta; Marc K Hellerstein; Kevan C Herold; Angela Lares; Michael R Lee; Kelvin Li; Weihong Liu; S Alice Long; Lisa M Masiello; Vinh Nguyen; Amy L Putnam; Mary Rieck; Peter H Sayre; Qizhi Tang
Journal:  Sci Transl Med       Date:  2015-11-25       Impact factor: 17.956

9.  The use of carboxyfluorescein diacetate succinimidyl ester (CFSE) to monitor lymphocyte proliferation.

Authors:  Benjamin J C Quah; Christopher R Parish
Journal:  J Vis Exp       Date:  2010-10-12       Impact factor: 1.355

10.  The second touch hypothesis: T cell activation, homing and polarization.

Authors:  Klaus Ley
Journal:  F1000Res       Date:  2014-02-05
View more
  10 in total

1.  Partial Clinical Remission of Type 1 Diabetes Mellitus in Children: Clinical Applications and Challenges with its Definitions.

Authors:  Benjamin Udoka Nwosu
Journal:  Eur Med J Diabetes       Date:  2019-03-14

Review 2.  Immunometabolism in biofilm infection: lessons from cancer.

Authors:  Rasoul Mirzaei; Niloofar Sabokroo; Yaghoub Ahmadyousefi; Hamid Motamedi; Sajad Karampoor
Journal:  Mol Med       Date:  2022-01-29       Impact factor: 6.354

3.  The Prognostic and Immunotherapeutic Significance of AHSA1 in Pan-Cancer, and Its Relationship With the Proliferation and Metastasis of Hepatocellular Carcinoma.

Authors:  Wenli Li; Jun Liu
Journal:  Front Immunol       Date:  2022-06-10       Impact factor: 8.786

4.  Efficacy of Acupuncture and Moxibustion as a Subsequent Treatment after Second-Line Chemotherapy in Advanced Gastric Cancer.

Authors:  Yong-Jie Zhang; Qi Min; Ying Huang; Huai-Dong Liu; Zi-Yuan Zhu; Fu-Jin Jiang; Hai-Qing Hua
Journal:  Evid Based Complement Alternat Med       Date:  2020-06-29       Impact factor: 2.629

5.  Effect of ligustrazine nanoparticles on Th1/Th2 balance by TLR4/MyD88/NF-κB pathway in rats with postoperative peritoneal adhesion.

Authors:  Lili Yang; Ziyu Lian; Bin Zhang; Zhengjun Li; Li Zeng; Wenlin Li; Yaoyao Bian
Journal:  BMC Surg       Date:  2021-04-26       Impact factor: 2.102

6.  Cancer-driven changes link T cell frequency to muscle strength in people with cancer: a pilot study.

Authors:  Aditi Narsale; Rosa Moya; Jasmin Ma; Lindsey J Anderson; Daniel Wu; Jose M Garcia; Joanna D Davies
Journal:  J Cachexia Sarcopenia Muscle       Date:  2019-04-12       Impact factor: 12.910

7.  Human Adipose Tissue-Derived Mesenchymal Stromal Cells Inhibit CD4+ T Cell Proliferation and Induce Regulatory T Cells as Well as CD127 Expression on CD4+CD25+ T Cells.

Authors:  Agnese Fiori; Stefanie Uhlig; Harald Klüter; Karen Bieback
Journal:  Cells       Date:  2021-01-01       Impact factor: 6.600

8.  CD4+CD25+CD127hi cell frequency predicts disease progression in type 1 diabetes.

Authors:  Aditi Narsale; Breanna Lam; Rosa Moya; TingTing Lu; Alessandra Mandelli; Irene Gotuzzo; Benedetta Pessina; Gianmaria Giamporcaro; Rhonda Geoffrey; Kerry Buchanan; Mark Harris; Anne-Sophie Bergot; Ranjeny Thomas; Martin J Hessner; Manuela Battaglia; Elisavet Serti; Joanna D Davies
Journal:  JCI Insight       Date:  2021-01-25

9.  Diminished Pneumococcal-Specific CD4+ T-Cell Response is Associated With Increased Regulatory T Cells at Older Age.

Authors:  Samantha W J He; Martijn D B van de Garde; Daan K J Pieren; Martien C M Poelen; Franziska Voß; Mohammed R Abdullah; Sven Hammerschmidt; Cécile A C M van Els
Journal:  Front Aging       Date:  2021-11-03

10.  A lipidated bi-epitope vaccine comprising of MHC-I and MHC-II binder peptides elicits protective CD4 T cell and CD8 T cell immunity against Mycobacterium tuberculosis.

Authors:  Pradeep K Rai; Sathi Babu Chodisetti; Sudeep K Maurya; Sajid Nadeem; Weiguang Zeng; Ashok K Janmeja; David C Jackson; Javed N Agrewala
Journal:  J Transl Med       Date:  2018-10-11       Impact factor: 5.531

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.